- Release Date: 29/05/24 09:03
- Summary: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
- Price Sensitive: Yes
- Download Document 2.8MB
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $24.82M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 33.0¢ | $18.15K | 54.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2827 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 372 | 1 |
View Market Depth
| Last trade - 10.41am 20/06/2024 (20 minute delay) ? |
| COV (ASX) Chart |